BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 14675859)

  • 1. Novel insight into the dangerous connection between diabetes and heart failure.
    Lombardi C; Spigoni V; Gorga E; Dei Cas A
    Herz; 2016 May; 41(3):201-7. PubMed ID: 27071966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of comorbidity on the benefits and harms of treatment for chronic disease: a systematic review.
    Fried TR; O'Leary J; Towle V; Goldstein MK; Trentelange M; Martin DK
    PLoS One; 2014; 9(11):e112593. PubMed ID: 25402463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carvedilol in the treatment of elderly patients with chronic heart failure.
    Witte KK; Clark AL
    Clin Interv Aging; 2008; 3(1):55-70. PubMed ID: 18488879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of carvedilol in very elderly diabetic patients with heart failure.
    Del Sindaco D; Pulignano G; Cioffi G; Tarantini L; Di Lenarda A; De Feo S; Opasich C; Minardi G; Giovannini E; Leggio F
    J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):675-82. PubMed ID: 17700396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.
    Capomolla S; Febo O; Gnemmi M; Riccardi G; Opasich C; Caporotondi A; Mortara A; Pinna GD; Cobelli F
    Am Heart J; 2000 Apr; 139(4):596-608. PubMed ID: 10740140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure.
    Macdonald PS; Keogh AM; Aboyoun CL; Lund M; Amor R; McCaffrey DJ
    J Am Coll Cardiol; 1999 Mar; 33(4):924-31. PubMed ID: 10091817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of carvedilol in congestive heart failure secondary to coronary artery disease.
    Das Gupta P; Broadhurst P; Raftery EB; Lahiri A
    Am J Cardiol; 1990 Nov; 66(15):1118-23. PubMed ID: 1977300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of the long-term administration of carvedilol in patients with chronic heart failure with and without concomitant diabetes mellitus.
    Nodari S; Metra M; Dei Cas A; Dei Cas L
    Eur J Heart Fail; 2003 Dec; 5(6):803-9. PubMed ID: 14675859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvedilol in the failing heart.
    Lombardi WL; Gilbert EM
    Clin Cardiol; 2001 Dec; 24(12):757-66. PubMed ID: 11768738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carvedilol: a review of its use in chronic heart failure.
    Keating GM; Jarvis B
    Drugs; 2003; 63(16):1697-741. PubMed ID: 12904089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvedilol: use in chronic heart failure.
    Doughty RN; White HD
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.